US Patent

US9233068 — Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders

Formulation · Assigned to Otonomy Inc · Expires 2029-12-11 · 4y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects controlled release compositions and methods for treating otic diseases or conditions with antimicrobial agents administered directly to the affected ear area.

USPTO Abstract

Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with antimicrobial agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

Drugs covered by this patent

Patent Metadata

Patent number
US9233068
Jurisdiction
US
Classification
Formulation
Expires
2029-12-11
Drug substance claim
No
Drug product claim
Yes
Assignee
Otonomy Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.